A demo for dungeon crawler RPG Curse Warrior will launch on March 12 at 00:00 in Japan, publisher Nippon Ichi Software and developer guruguru announced.

Malware is evolving to evade sandboxes by pretending to be a real human behind the keyboard. The Picus Red Report 2026 shows 80% of top attacker techniques now focus on evasion and persistence, ...

BRUSSELS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source software organisations, has announced the full agenda for Open Community Experience (OCX 2026 ...

This story has been updated with new information. Detroit Mayor Mary Sheffield has instated tighter controls over the city's demolition program and ordered the expansion of notifications to residents ...

Contaminated dirt is once again a problem in Detroit's demolition program, with testing underway at more than 500 sites connected to a demolition contractor and a city-approved dirt supplier. Gayanga ...

Belgian studio Happy Volcano is powering up its factory-building sandbox Modulus. Fresh from the Steam Automation Fest, the team announced a revamped demo, a brand-new Creator Program, and a confirmed ...

Bandai Namco has released an eight-minute “walkthrough” trailer for Code Vein II, as well as announced that a “Character Creator Demo” will be available starting January 23. The “Character Creator ...

When available, the best way to check out an upcoming game is with a demo on the PS Store. Although January isn’t the hottest month for game releases, one of the bigger games to release this month, ...

The announcement image highlighted what we’ll see in it. It will be possible to use the full character creator for the game. The person we make can then be exported and used in a full copy of the game ...

Paired with a new 8-minute gameplay video, the Code Vein 2 character creation demo was also announced. In this demo, you’ll be able to create your starter character. Compared to the first title, this ...

The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it's unclear how ...